Morphic Therapeutic
MORF
$29.90
Share price
4.14%
Change (1 day)
-38.34%
Change (1 year)
Categories
Morphic Therapeutic (MORF) - Cash on Hand
Cash on Hand as of March 2024 : $0.65 B
According to Morphic Therapeutic's latest financial reports the company has $0.65 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Morphic Therapeutic - Cash on Hand chart (from 2018 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.70 B | 102.26% |
| 2022-12-31 | $0.34 B | -14.67% |
| 2021-12-31 | $0.40 B | 78.8% |
| 2020-12-31 | $0.22 B | -3.69% |
| 2019-12-31 | $0.23 B | 27.5% |
| 2018-12-31 | $0.18 B | 795.91% |
| 2017-12-31 | $20.75 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $95.88 M | -85.45% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $20.82 M | -96.84% | 🇺🇸 USA |